Search Results 1061-1070 of 18669 for Relapse

  1. Burkitt lymphoma - Diagnosis and treatment - Mayo Clinic

    ... relapse. For Burkitt lymphoma, most relapses happen in the first year after treatment. You may have repeat blood and imaging tests and, if needed, biopsies ...

  2. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

    - Relapsed after or failed to respond to at least one prior treatment regimen containing a Bruton's tyrosine kinase (BTK) inhibitor - Adequate renal ...

  3. Daratumumab (intravenous route) - Side effects & uses - Mayo Clinic

    ... relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma who have received at least 1 previous treatment.

  4. Salvage Therapy Clinical Trials - Mayo Clinic Research

    ... relapsed within 6 months, after first-line AML therapy. Outcomes for Hand and Foot Soft Tissue Sarcomas Treated with Limb Sparing Multimodal Therapy ...

  5. Clinical trials - Oncology (Medical)

    CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies ... relapse, and subsequent therapy. Effect of Agent Orange ...

  6. Obsessive-compulsive disorder (OCD) - Diagnosis and treatment - Mayo Clinic

    You may have a relapse of OCD symptoms. Work with your doctor to lower your dose safely over time. Talk to your doctor about the risks and benefits of using ...

  7. Use of smartphone-enabled mood assessments and sensor data to predict alcohol craving in patients with alcohol-associated liver disease and alcohol use disorder - Mayo Clinic

    ... relapse and management of alcohol-associated liver disease," explains Dr. Wu ... Wu and co-authors note that larger studies are needed to validate smartphone ...

  8. Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma - Mayo Clinic

    Participation eligibility · Patients being staged for multiple myeloma as follows: new diagnosis, high risk smoldering multiple myeloma, relapsed as defined by ...

  9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Each unique regimen or 'line' is defined as a single or combination of medications given for a new relapse/recurrence. Maintenance therapies, where ...

  10. Kidney Tumors Clinical Trials - Mayo Clinic Research

    A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma ...